Ron DePinho: A Negative Trial Highlights the Need for Precision in Cardiovascular Inflammation
Ron DePinho, Professor at Department of Cancer Biology, Harry Graves Burkhart III Distinguished University Chair Cancer Biology at MD Anderson Cancer Center, shared a post on LinkedIn:
“Disappointing for this program, but definitely not a repudiation of inflammation as a cardiovascular target.
The key question will be whether the trial tested the right inflammatory biology, in the right patients, at the right stage of disease.
Cardiovascular inflammation is not a single pathway or biomarker; it is a dynamic network shaped by residual lipid risk, obesity and metabolic dysfunction, clonal hematopoiesis, immune aging, and tissue injury.
The field should learn as much from a negative trial as from a positive one.
We need better mechanistic patient stratification, pharmacodynamic biomarkers that demonstrate pathway engagement in the relevant tissue, and combination strategies matched to the biology of residual risk.
The inflammatory hypothesis remains compelling in my view… it is likely that its clinical translation clearly requires greater precision.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 14:09Emmanuel J Favaloro: 100 years of von Willebrand Disease (VWD) in 2026
-
Oct 10, 2026, 13:54WFH Strengthens Collaboration to Advance Hemophilia Care in Paraguay
-
Oct 10, 2026, 13:40Shayan Mohammadmoradi: Platelets as Stress Sensors A New Perspective on Platelet Biology
-
Oct 10, 2026, 13:32Edward Lee Carter: When Normal Ferritin Does Not Rule Out Iron Deficiency
-
Oct 10, 2026, 13:15Meet NNHF at ASCAT 2026 – Novo Nordisk Haemophilia and Haemoglobinopathies Foundation
-
Oct 10, 2026, 11:32Thrombus Age Assessment Through Advanced Imaging and Biomarkers
-
Oct 10, 2026, 10:55Tzu-Fei Wang: How Should We Approach Anticoagulation for Cancer-Associated Gonadal and Renal Vein Thrombosis?
-
Oct 10, 2026, 10:50Robert Sidonio Joins ATHN Advanced Clinical Research Fellowship Program
-
Oct 10, 2026, 10:45Federica Fogacci: Co-Moderating at CA Meet 2026 in Padua – Elevating Lifestyle Interventions in Cardiology